Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes
- 9 January 2001
- journal article
- clinical trial
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 303 (1-2), 167-179
- https://doi.org/10.1016/s0009-8981(00)00396-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cardiac troponins: IT upgrade for the heartThe Lancet, 1998
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoringCoronary Artery Disease, 1995
- Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase-2 (mass), and troponin TClinical Biochemistry, 1994
- Failure of new biochemical markers to exclude acute myocardial infarction at admissionThe Lancet, 1993
- Early Diagnosis of Acute Myocardial Infarction: CK-MB and Myoglobin ComparedAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1993
- Troponin-T and CK MB (Mass) in early diagnosis of ischemic myocardial injury. The Helsingborg study, 1992Clinical Biochemistry, 1993
- Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobinHeart, 1992
- Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation.Heart, 1990
- Myoglobinemia in the early phase of acute myocardial infarctionAmerican Heart Journal, 1983